🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Not Yet Recruiting
Location
Peking Union Medical College Hospital
Start Date
2026-06
Trial ID
NCT07642843
Treatments Being Tested
The purpose of this study is to compare the efficacy between CM336 and inve...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2025-09
Trial ID
NCT07181239
Treatments Being Tested
This is a single-arm, open-label study to evaluate the efficacy and safety ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-01
Trial ID
NCT07648459
Treatments Being Tested
To evaluate the efficacy and safety of CM336 in the treatment of refractory...
Status
Recruiting
Location
Chinese Academy of Medical Science and Blood Disease Hospital
Start Date
2025-03-03
Trial ID
NCT06799611
Treatments Being Tested
This is a multi-center, open-label, Phase 1/2 study in China to evaluate th...
Status
Recruiting
Location
Peking University Third Hospital
Start Date
2022-08-09
Trial ID
NCT05299424
to Evaluate the Efficacy and Safety of CM336 (BCMA/CD3 Bispecific Antibody)...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-07-25
Trial ID
NCT07039578
Treatments Being Tested
To evaluate the efficacy and safety of CM336 (BCMA/CD3 Bispecific Antibody)...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2025-11-18
Trial ID
NCT07175493
Treatments Being Tested
This is a prospective, single-arm clinical study designed to evaluate the e...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2026-07-07
Trial ID
NCT07409454
Treatments Being Tested
to Evaluate the Efficacy and Safety of CM336 (BCMA/CD3 Bispecific Antibody)...
Status
Recruiting
Location
Dermatology Hospital Affiliated to Shandong First Medical University
Start Date
2025-04-22
Trial ID
NCT06900010
Treatments Being Tested